Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Type 1 or 2 Diabetes”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Testing effectiveness (Phase 2)UnknownNCT05333835
What this trial is testing

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 455
Testing effectiveness (Phase 2)Study completedNCT00320060
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 128
Testing effectiveness (Phase 2)Ended earlyNCT01113801
What this trial is testing

A Study in Participants With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis
Eli Lilly and Company 417
Testing effectiveness (Phase 2)Study completedNCT04265261
What this trial is testing

Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Hoffmann-La Roche 139
Not applicableEnded earlyNCT02080741
What this trial is testing

Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Who this might be right for
Patients With Type 1 or Type 2 DiabetesPatients With a Type A or B Behaviour Profile
Centre Hospitalier Universitaire Dijon 57
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Early research (Phase 1)Study completedNCT01474161
What this trial is testing

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Who this might be right for
Type 2 DiabetesDiabetes Mellitus, Type 2Metabolic Diseases+3 more
Genfit 96
Not applicableStudy completedNCT07141940
What this trial is testing

Indonesian-Language Application-Based Guided Imagery Therapy for Insomnia and Glycemic Control in Diabetic Patients

Who this might be right for
Diabetes (Insulin-requiring, Type 1 or Type 2)Insomnia Type; Sleep DisorderFasting Plasma Glucose
Dr Cipto Mangunkusumo General Hospital 66
Post-approval studies (Phase 4)UnknownNCT03444142
What this trial is testing

Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
University of Guadalajara 30
Not applicableStudy completedNCT00286572
What this trial is testing

Long-term Mortality in Diabetics Undergoing Major Surgery

Who this might be right for
Diabetes MellitusCoronary Heart DiseaseMajor Non-cardiac Surgery
University Hospital, Basel, Switzerland 380
Testing effectiveness (Phase 2)Looking for participantsNCT06845202
What this trial is testing

Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Who this might be right for
Obese or Overweight Healthy VolunteersType 2 Diabetes Mellitus (T2DM)
Alnylam Pharmaceuticals 144
Testing effectiveness (Phase 2)Study completedNCT04663282
What this trial is testing

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 179
Testing effectiveness (Phase 2)Study completedNCT01194245
What this trial is testing

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
Halozyme Therapeutics 135
Not applicableStudy completedNCT07052292
What this trial is testing

User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 128
Not applicableNot Yet RecruitingNCT07004153
What this trial is testing

DIA:CONN P8 Smart Insulin Pen With CGM-Based Coaching in Patients With Type 1 or Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
G2e Co., Ltd 152
Large-scale testing (Phase 3)Study completedNCT00191581
What this trial is testing

Local Registration Trial in China Humalog Mix 50

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 120
Not applicableStudy completedNCT00665093
What this trial is testing

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,569
Not applicableLooking for participantsNCT06046833
What this trial is testing

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Gastroparesis With Diabetes Mellitus
Samita Garg 50
Early research (Phase 1)Study completedNCT06615700
What this trial is testing

Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus

Who this might be right for
Overweight or ObesityType 2 Diabetes
Biomed Industries, Inc. 74
Post-approval studies (Phase 4)Study completedNCT05857085
What this trial is testing

Novel Therapeutics and Endothelial Dysfunction in T1DM Patients

Who this might be right for
Endothelial DysfunctionDiabetes Mellitus, Type 1Biomarkers+7 more
General and Teaching Hospital Celje 90
Load More Results